Barry E Greene Karyopharm Therapeutics Inc. (KPTI) insider trading activity

KPTI Quotes by TradingView

Barry E Greene is of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 13,606 shares of KPTI, which is worth approximately $8,435. The most recent transaction as insider was on Aug 11, 2022, when has been sold 7,576 shares (Common Stock) at a price of $1.49 per share, resulting in proceeds of $11,288. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.6K
0% 3M change
0% 12M change
Total Value Held $8,435

Barry E Greene Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 11 2022
BUY
Exercise of conversion of derivative security
$11,288 $1.49 p/Share
7,576 Added 35.77%
13,606 Common Stock

Also insider at

SAGE
Sage Therapeutics, Inc. Healthcare
President and CEO
ACOR
ACORDA THERAPEUTICS INC Healthcare
Director
BEG

Barry E Greene

Newton, MA

Track Institutional and Insider Activities on KPTI

Follow Karyopharm Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPTI shares.

Notify only if

Insider Trading

Get notified when an Karyopharm Therapeutics Inc. insider buys or sells KPTI shares.

Notify only if

News

Receive news related to Karyopharm Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KPTI